Electric fields zap pancreatic tumors in major trial
Disease control
Completed
This large, completed Phase 3 trial tested whether adding a portable, battery-operated device to standard chemotherapy could help people with advanced pancreatic cancer live longer. The device, worn on the abdomen, delivers low-intensity electric fields (called TTFields) aimed at…
Phase: PHASE3 • Sponsor: NovoCure Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC